Page last updated: 2024-11-12

indolapril hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Indolapril: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10457278
CHEMBL ID3707361
SCHEMBL ID635729
MeSH IDM0578188

Synonyms (25)

Synonym
sch 31846 hydrochloride
1h-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, monohydrochloride, (2s-(1(r*(r*)),2alpha,3abeta,7abeta))-
1h-indole-2-carboxylic acid, octahydro-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxypropyl)-, monohydrochloride, (2s-(1(r*(r*)),2-alpha,3-alpha-beta,7-alpha-beta))-
indolapril hydrochloride [usan]
ci 907
indolapril hydrochloride
(2s,3as,7as)-1-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, monohydrochloride
indolapril hydrochloride (usan)
D03756
80828-32-6
pd-109763-2
sch-31846
indolapril
ci-907
indolapril hcl
rev 6000a(ss)
unii-qmi2cz2c4p
qmi2cz2c4p ,
1h-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, monohydrochloride, (2s-(1(r*(r*)),2.alpha.,3a.beta.,7a.beta.))-
(2s,3as,7as)-1-[(s)-n-[(s)-1-carboxy-3-phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, monohydrochloride
SCHEMBL635729
CHEMBL3707361
Q27287339
(2s,3as,7as)-1-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;hydrochloride
AKOS040748579

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"5 g/kg, respectively, while the iv LD50 was approximately 450 mg/kg in mice and 150 mg/kg in rats."( Acute and subchronic toxicity of a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Black, HE; La Rocca, PT; Powell, ML; Schwartz, E; Squibb, RE; Szot, RJ, 1986
)
0.27

Bioavailability

ExcerptReferenceRelevance
" Absorption studies in male rats at doses of 30, 180, and 600 mg/kg indicate that SCH 31846 is well absorbed in rats."( Acute and subchronic toxicity of a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Black, HE; La Rocca, PT; Powell, ML; Schwartz, E; Squibb, RE; Szot, RJ, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]